Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - CALYPTE BIOMEDICAL CORP | calypte_10k-123110.htm |
| EX-32.1 - EXHIBIT 32.1 - CALYPTE BIOMEDICAL CORP | ex32-1.htm |
| EX-31.1 - EXHIBIT 31.1 - CALYPTE BIOMEDICAL CORP | ex31-1.htm |
| EX-10.200 - EXHIBIT 10.200 - CALYPTE BIOMEDICAL CORP | ex10-200.htm |
| EX-10.146 - EXHIBIT 10.146 - CALYPTE BIOMEDICAL CORP | ex10-146.htm |
Exhibit 23.1
We consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-106389, No. 333-127089 and No. 333-127090) and Form S-3 (No. 333-119646, No. 333-125051, and No. 333-126460) of our report dated May 20, 2011, relating to the consolidated financial statements of Calypte Biomedical Corporation (which report expresses an unqualified opinion and includes a matter of emphasis paragraph relating to the Company’s ability to continue as a going concern) included in this Annual Report on Form 10-K for the year ended December 31, 2010.
/s/ Odenberg, Ullakko, Muranishi & Co. LLP
San Francisco, California
May 20, 2011